We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Aimmune Therapeutics said that 80 percent of allergic patients in a trial of its oral immunotherapy Palforzia (peanut allergen powder-dnfp) were desensitized to peanut proteins. Read More
AstraZeneca has licensed six monoclonal antibodies from Vanderbilt University and plans to advance the most promising ones for prevention and treatment of COVID-19. Read More
The European Medicines Agency (EMA) said it is giving a fast-track review to a conditional marketing authorization request from Gilead Sciences for using remdesivir to treat COVID-19 patients. Read More
Regeneron Pharmaceuticals and Vir Biotechnology said they will soon begin clinical trials of monoclonal antibodies they hope will be able to prevent or treat COVID-19 patients. Read More
The FDA yesterday released a temporary final guidance allowing drug companies to ship samples directly to a patient’s home during the pandemic, as long as their practitioner has given permission. Read More
The FDA has launched a pilot program with the National Telecommunications and Information Administration (NTIA) to curb illegal opioid sales online. Read More